State of Wyoming Purchases 6,138 Shares of CVS Health Corporation $CVS

01 Nov 2026, 10:43 by Michael Walen · The Markets Daily

State of Wyoming raised its position in shares of CVS Health Corporation (NYSE:CVS – Free Report) by 247.4% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,619 shares of the pharmacy operator’s stock after buying an additional 6,138 shares during the period. State of Wyoming’s holdings in CVS Health were worth $739,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. Handelsbanken Fonder AB grew its stake in shares of CVS Health by 83.6% in the second quarter. Handelsbanken Fonder AB now owns 1,089,694 shares of the pharmacy operator’s stock worth $112,729,000 after purchasing an additional 496,124 shares during the last quarter. BNP Paribas increased its holdings in CVS Health by 105.2% during the 2nd quarter. BNP Paribas now owns 49,971 shares of the pharmacy operator’s stock valued at $5,154,000 after purchasing an additional 25,617 shares during the period. Nykredit A S purchased a new position in CVS Health during the 2nd quarter valued at about $209,813,000. Oppenheimer Asset Management Inc. bought a new position in CVS Health during the 2nd quarter valued at approximately $49,622,000. Finally, Bank of America Corp DE raised its position in CVS Health by 148.0% during the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock valued at $2,398,868,000 after purchasing an additional 13,836,701 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on CVS shares. Sanford C. Bernstein reiterated an “outperform” rating and issued a $112.00 price objective on shares of CVS Health in a report on Wednesday, September 9th. BMO Capital Markets set a $112.00 target price on CVS Health in a research note on Wednesday, September 9th. Leerink Partners decreased their target price on CVS Health from $119.00 to $112.00 and set an “outperform” rating for the company in a report on Monday, October 12th. Wall Street Zen lowered CVS Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, October 19th. Finally, HSBC reiterated a “hold” rating and issued a $103.00 price target on shares of CVS Health in a report on Monday, July 6th. Nineteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $109.64.

Check Out Our Latest Stock Report on CVS Health

Trending Headlines about CVS Health

Here are the key news stories impacting CVS Health this week:

Positive Sentiment: One valuation analysis estimates that CVS could be approximately 27% undervalued, citing its low valuation and expectations that upcoming earnings will clarify performance across its pharmacy, insurance and healthcare-services businesses. CVS Health Could Be 27% Undervalued
Positive Sentiment: CVS is promoting free Project Health screenings that require no appointment or insurance. Although primarily a community-health initiative, the program may support customer engagement and the company’s broader healthcare strategy. CVS Project Health Screenings
Neutral Sentiment: Wall Street is reportedly expecting about $1.62 in third-quarter earnings per share, with analysts examining metrics beyond revenue and EPS, including segment trends and operating performance. The results could provide an important catalyst after CVS’s previous quarterly earnings beat. CVS Q3 Earnings Estimates
Neutral Sentiment: CVS is highlighting medication-safety education and substance-misuse prevention resources. The initiative strengthens its public-health positioning but is unlikely to materially affect near-term earnings. CVS Medication Safety Initiative
Negative Sentiment: CVS faces a reported risk of roughly $2 billion related to Medicare Advantage star ratings. Lower ratings could reduce bonus payments and pressure profitability in its insurance business. CVS Medicare Ratings Risk
Negative Sentiment: Six hospital systems, including the University of Kentucky, reportedly accuse CVS of fraud or contract breaches, with the Kentucky lawsuit seeking $41 million. Even if the claims are unresolved, additional litigation raises potential legal costs and reputational risk. Hospital Systems Sue CVS

CVS Health Price Performance

CVS stock opened at $90.20 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The firm has a 50-day moving average of $91.22 and a 200 day moving average of $88.76. The company has a market cap of $115.36 billion, a P/E ratio of 23.86, a PEG ratio of 0.84 and a beta of 0.60.

CVS Health (NYSE:CVS – Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%. The business had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. During the same period in the previous year, the firm posted $1.81 EPS. The business’s revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, sell-side analysts forecast that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd will be paid a $0.6650 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date is Thursday, October 22nd. CVS Health’s dividend payout ratio (DPR) is presently 70.37%.

About CVS Health

(Free Report)

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.